$AVNR News 4 stocks to watch 3:47 p.m. Sept. 18, 2014 -

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2014 at 12:28 PM

$AVNR News

4 stocks to watch 3:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy

Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape 8:52 a.m. Sept. 19, 2014 - Zacks.com
Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog 7:00 p.m. Sept. 18, 2014 - Zacks.com
Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders 10:30 a.m. Sept. 18, 2014 - TheStreet.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog 3:00 p.m. Sept. 17, 2014 - Zacks.com
All Pop And No Sizzle Or Is Avanir Going Higher From Here? 9:30 a.m. Sept. 17, 2014 - Seeking Alpha
Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog 4:14 p.m. Sept. 16, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today 9:45 a.m. Sept. 16, 2014 - TheStreet.com
Is Avanir Pharma Fully Valued After Monday’s Rally? 9:13 a.m. Sept. 16, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:11 a.m. Sept. 16, 2014 - benzinga.com
Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today 4:06 p.m. Sept. 15, 2014 - TheStreet.com
Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog 3:42 p.m. Sept. 15, 2014 - Zacks.com
Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge 2:40 p.m. Sept. 15, 2014 - benzinga.com
Concert Pharma rides Avanir's coattails 1:30 p.m. Sept. 15, 2014 - Seeking Alpha
NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer 12:24 p.m. Sept. 15, 2014 - benzinga.com
Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More 11:32 a.m. Sept. 15, 2014 - benzinga.com
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs 10:26 a.m. Sept. 15, 2014 - 247WallSt.com
Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion 10:26 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Movers 8:42 a.m. Sept. 15, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com

Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 9:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 8:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 8:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 8:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:15 a.m. July 21, 2014 - PR Newswire - PRF
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 11:50 a.m. July 15, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association International Conference (AAIC) 7:22 p.m. June 30, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Sarepta Under Scrutiny: KSF's Investigation Deepens

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Court Enforces Design Rights: AEKE Blocked in Germany

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

LG's High-Purity RGB Displays Shine at IFA 2026

LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...

Signant and Lothar Forge Future in Clinical Trials

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Why Buyers Are Flocking to Whidbey Island Homes

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Auto Maintenance: Key Tips for Long-Term Vehicle Health

Beating Breakdown Blues: Preventative Maintenance Insights You ever look under the hood and wonder what's ticking away? Cars ain't just about turning keys and hitting gas—there's a beating heart under all that metal and rubber. That's what HelloNation's serving us here, with David Mantz and his kid, David Mantz Jr., lifting the lid on preventative maintenance. These...

Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

UGREEN's AI Hub: Privacy-First Tech for Smart Homes

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...